Skip to main content

Day: February 3, 2021

Global Care Capital Portfolio Company, HealthView, Onboards First Customers Across Retail, Hospitality, Medical, Finance and Transportation Industries

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies is pleased to announce that its 100% owned portfolio company, HealthView Technologies Inc. (“HealthView”) has onboarded its first customers across the retail, hospitality, medical, finance and transportation industries to offer Mental Health Services and has achieved its first of two earn-out milestones in accordance with the terms of the definitive agreement that was entered in connection with the acquisition of HealthView by the Company (the “Transaction”).On January 25th, 2021,...

Continue reading

argenx raises $1.0 billion in gross proceeds in a global offering

Regulated information — Inside informationFebruary 2, 2021, 10:15 PM ESTFebruary 3, 2021, 4:15 AM CETBreda, the Netherlands — argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced today the pricing of a global offering of ordinary shares represented by American Depository Shares (ADSs) in the United States and certain other countries outside of European Economic Area and a simultaneous private placement of ordinary shares in the European Economic Area and the United Kingdom. The Company anticipates total gross proceeds of approximately $1.0 billion (approximately €830.3 million) from the sale of 1,608,000 ADSs at a price of $320.00 per ADS and the sale of 1,517,000 ordinary shares at a price of €265.69 per ordinary...

Continue reading

Affinor Growers Announces Appointment of Nick Brusatore to Audit Committee

VANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI) (OTCQB: RSSFF) is pleased to announce that Nick Brusatore has been appointed as a non-independent member of the Company’s Audit Committee. Mr. Brusatore will also continue in his roles as Chief Executive Officer and as director of the Company.Nick Brusatore: This is a great first step in building trust with our current shareholder base, we hope to increase our exposure in the market with the completion of the new Abbotsford greenhouse operation.About AffinorAffinor is a publicly traded company listed on the CSE under the symbol “AFI” and on the OTCQB under the symbol “RSSFF”. Affinor is focused on developing vertical farming technologies and using those technologies to grow fruits and vegetables...

Continue reading

Kernel Group Holdings, Inc. Announces Pricing of Upsized $265 Million Initial Public Offering

SAN FRANCISCO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Kernel Group Holdings, Inc. (the “Company”) today announced the pricing of its upsized initial public offering of 26,500,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “KRNLU” beginning on February 3, 2021. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “KRNL” and “KRNLW,” respectively. The initial public offering is expected to close on February 5, 2021, subject to customary closing...

Continue reading

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock

PITTSBURGH, Feb. 02, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc. (NASDAQ: KRYS) (the “Company), the leader in redosable gene therapies for rare diseases, today announced that it has priced the previously announced underwritten public offering of 1,923,077 shares of its common stock, at a public offering price of $65.00 per share. The Company granted the underwriters a 30-day option to purchase up to an additional 288,461 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $125 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 5, 2021, subject to satisfaction of customary closing conditions.Goldman Sachs & Co. LLC, Cowen, and Evercore...

Continue reading

Itafos Announces Appointment of Chief Strategy Officer

TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Itafos (TSX-V: IFOS) (the “Company”) announced today the appointment of David Brush as Chief Strategy Officer, effective January 1, 2021. Mr. Brush has been serving as a consultant since December 1, 2020. In his role as Chief Strategy Officer, Mr. Brush will be responsible for strategy development and implementation, including related capital structuring and corporate development initiatives.“We are pleased to bolster our management team by adding Dave’s experience and expertise in strategy, finance and operations. Dave will be instrumental as we look to improve our capital structure and pursue growth opportunities in the agricultural sector,” said G. David Delaney, CEO of Itafos.Mr. Brush is a senior executive with over 30 years’ experience in all aspects of global business operations,...

Continue reading

Arcutis Biotherapeutics Announces Pricing of Upsized Public Offering of Common Stock

WESTLAKE VILLAGE, Calif,, Feb. 02, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced the pricing of its upsized underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $35.00 per share. In addition, Arcutis has granted the underwriters a 30-day option to purchase up to an additional 825,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Arcutis from the offering are expected to be $192.5 million, before deducting underwriting discounts and commissions and estimated offering expenses...

Continue reading

Lantronix Names SAPPLY Australasia Distributor

IRVINE, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of Software as a Service (SaaS), engineering services and hardware for Edge Computing, the Internet of Things (IoT) and Remote Environment Management (REM), today named SAPPLY as its Australasia Distributor. SAPPLY is now offering Lantronix’s complete portfolio of software, hardware, and services.“We are pleased to add SAPPLY to our network of authorized distributors,” said Roger Holliday, VP of Worldwide Sales at Lantronix. “They will provide support to our growing customer base in the Australasia region.”“Lantronix’s cutting-edge technologies and services deliver a holistic approach to connectivity by integrating software, hardware and application development,” said Neil Woolley, director of SAPPLY. “As Lantronix’s Australasian distributor,...

Continue reading

Rackspace Technology Announces Pricing of $550 Million Notes Offering by Rackspace Technology Global

SAN ANTONIO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT) today announced that its wholly owned subsidiary Rackspace Technology Global, Inc. (the “Company”) has priced its offering of $550.0 million aggregate principal amount of 3.50% First-Priority Senior Secured Notes due 2028 (the “Notes”) at an issue price of 100.000%. The closing of the offering is expected to occur on February 9, 2021 and is subject to customary closing conditions.The Company intends to use the net proceeds from the offering, together with borrowings under a new senior secured first lien term loan facility, to repay the borrowings outstanding under its existing term loan facility, to pay related fees and expenses and for general corporate purposes.The Notes are being offered only to persons reasonably believed to be qualified...

Continue reading

Caldas Gold Announces Completion of Marmato Mining Title Extension to 2051

TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Caldas Gold Corp. (TSX-V: CGC; OTCQX: ALLXF) announced today that it has received official notification from the Agencia Nacional de Mineria (“ANM”) confirming that the 30-year extension of its Marmato mining contract 014-89M has been approved and has been registered in the Colombian National Mining Registry.Serafino Iacono, Chairman and CEO of Caldas Gold, said, “We are very pleased to announce the successful conclusion of the mining title extension process. Marmato is a world class project and our significant investment in the future expansion of its underground mining operations will benefit all stakeholders including our investors, the nation of Colombia, the Department of Caldas and the local community at Marmato. We would like to take this opportunity to sincerely thank all those who...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.